Research programme: neurological disorder therapeutics - NeuroFront
Latest Information Update: 01 Dec 2021
At a glance
- Originator NeuroFront
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Neurological disorders
Most Recent Events
- 01 Dec 2021 Early research in Neurological disorders in China (unspecified route) before December 2021 (NeuroFront website, December 2021)